FluoroPharma Medical, Inc. (FPMI)

Market Cap	28.00
Revenue (ttm)	n/a
Net Income (ttm)	-2.57M
Shares Out	27.58M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,412,600
Average Volume	91,343
Open	0.0001
Previous Close	0.0001
Day's Range	0.0000 - 0.0001
52-Week Range	0.0000 - 0.0001
Beta	-86.98
RSI	28.99
Earnings Date	n/a

About FluoroPharma Medical

FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in pati...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: FPMI